Table 4.
Factors associated with SMARCA2-negative expression in NSCLC patients.
| Factors | OR | 95% Confidence interval | P-value |
| Gender | |||
| Female | 1.000 | ||
| Male | 1.452 | 1.072–1.968 | 0.016* |
| T-stage | |||
| T1 | 1.000 | ||
| T2 | 1.061 | 0.755–1.486 | 0.731 |
| T3 | 3.069 | 1.564–5.881 | 8.574E-04* |
| T4 | 2.495 | 1.036–5.564 | 0.031* |
| Tumor location | |||
| Upper & lower lobe | 1.000 | ||
| Middle lobe | 2.022 | 1.257–3.218 | 2.623E-03* |
| Differentiation states | |||
| Well | 1.000 | ||
| moderate | 2.772 | 1.588–5.143 | 6.150e-04* |
| Poor | 4.965 | 2.791–9.374 | 1.830E-07* |
| Tumor size | |||
| <2 cm | 1.000 | ||
| ≥2 cm | 1.848 | 1.310–2.626 | 5.304E-04* |
| Classification | |||
| SCC | 1.000 | ||
| AD | 3.413 | 1.766–7.115 | 5.065E-04* |
| Others | 6.931 | 1.813–24.278 | 2.959E-03* |
| Ki67 | |||
| <15% | 1.000 | ||
| ≥15% | 1.457 | 1.014–2.105 | 0.043* |
| SOX-2 | |||
| Positive | 1.000 | ||
| Negative | 2.586 | 1.774–3.855 | 1.539E-06* |